United States · Bill · HR
H.R. 2518 (112th)
To extend for 5 years the authorization of appropriations for the sickle cell disease prevention and treatment demonstration program.
Introduced
13 July 2011
Last action
15 July 2011 · Referred
Status
Referred to the Subcommittee on Health.
Sponsors
Rep. Davis, Danny K. [D-IL-7], JOHN SHIMKUS, PETER VISCLOSKY, Rep. Bishop, Sanford D. [D-GA-2]
Subjects
Healthcare
Source updated
3 January 2025
Summary
Amends the American Jobs Creation Act of 2004 to reauthorize appropriations for FY2013-FY2017 for a demonstration program to develop and establish systemic mechanisms to improve the prevention and treatment of Sickle Cell Disease.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
13 July 2011
Introduced
Referred to the House Committee on Energy and Commerce.
Source: IntroReferral
13 July 2011
Introduced
Introduced in House
Source: IntroReferral
13 July 2011
Introduced
Introduced in House
Source: IntroReferral
15 July 2011
Referred
Referred to the Subcommittee on Health.
Source: Committee
Votes
No vote records are attached yet.
Versions
- Introduced in House · 13 July 2011 · Official file
Documents
3 official files
Introduced in House (text)
Introduced in House (text)
Introduced in House · EN · 13 July 2011
Introduced in House (PDF)
Introduced in House · EN · 13 July 2011
Introduced in House
summary · EN · 13 July 2011
Sponsors
- Rep. Davis, Danny K. [D-IL-7] · D · Sponsor
- JOHN SHIMKUS · R · Sponsor
- PETER VISCLOSKY · D · Cosponsor
- Rep. Bishop, Sanford D. [D-GA-2] · D · Cosponsor
- · hsif00 · Standing
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.congress.gov/bill/112th-congress/house-bill/2518
- Open data entity: https://api.congress.gov/v3/bill/112/hr/2518
- us · 112-hr-2518 · source updated 3 January 2025